DYSHEMATOPOIESIS IN COMBINED IMMUNE-DEFICIENCY WITH CONGENITAL NEUTROPENIA

被引:2
作者
GASPARETTO, C
SMITH, C
FIRPO, M
DENNIG, D
SMALL, T
GILLIO, AP
LICHTENBERG, R
OREILLY, RJ
MOORE, MAS
机构
[1] MEM SLOAN KETTERING CANC CTR,BONE MARROW TRANSPLANT SERV,NEW YORK,NY 10021
[2] MEM SLOAN KETTERING CANC CTR,DIV HEMATOL ONCOL,NEW YORK,NY 10021
[3] MEM SLOAN KETTERING CANC CTR,JAMES EWING LAB DEV HEMATOPOIESIS,NEW YORK,NY 10021
[4] LOYOLA UNIV,STRITCH SCH MED,DEPT MED & PEDIAT,MAYWOOD,IL 60153
关键词
COMBINED IMMUNE DEFICIENCY; CONGENITAL NEUTROPENIA; CYTOKINE COMBINATIONS;
D O I
10.1002/ajh.2830450110
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This report describes a patient with combined immune deficiency associated with congenital neutropenia (CID/CN) and reports a partial characterization of his hematopoietic abnormalities. The CID/CN syndrome described is characterized by neutropenia and by deficiencies in B-lymphoid and T-lymphoid cell number and function. Red cell and platelet counts were normal. In vitro assays indicate that the myeloid lineage was developmentally arrested at the level of the committed monocyte/granulocyte progenitor (CFU-GM), while precursors to the CFU-GM progenitor were normal. In vitro studies showed that the defect in myeloid development was not corrected with G-CSF or GM-CSF. However, combinations of cytokines present in conditioned media from the T-cell lines MO or C5MJ, or defined multiple cytokine combinations containing IL-1, IL-3, GM-CSF, kit ligand, IL-6, and IL-9, restored myelopoiesis in-vitro. In contrast, C5MJ-conditioned media did not correct deficiencies in immune function in the patient's lymphocytes and accessory cells. No abnormalities in the production of G-CSF, GM-CSF, M-CSF, or IL-1 from the patient could be identified to account for the defects in myelopoiesis orimmune function. (C) 1994 Wiley-Liss, Inc.
引用
收藏
页码:63 / 72
页数:10
相关论文
共 31 条
[1]  
BASSON JC, 1985, PROG CLIN BIOL RES, V184, P95
[2]   EFFECTS OF RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR ON NEUTROPENIA IN PATIENTS WITH CONGENITAL AGRANULOCYTOSIS [J].
BONILLA, MA ;
GILLIO, AP ;
RUGGEIRO, M ;
KERNAN, NA ;
BROCHSTEIN, JA ;
ABBOUD, M ;
FUMAGALLI, L ;
VINCENT, M ;
GABRILOVE, JL ;
WELTE, K ;
SOUZA, LM ;
OREILLY, RJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (24) :1574-1580
[3]  
BROXMEYER HE, 1991, BLOOD, V77, P2142
[4]  
BUCKLEY RH, 1987, JAMA-J AM MED ASSOC, V258, P2841
[5]  
CASHMAN JD, 1990, BLOOD, V75, P96
[6]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[7]   CONGENITAL NEUTROPENIA - STUDIES OF PATHOGENESIS [J].
CHUSID, MJ ;
PISCIOTTA, AV ;
DUQUESNOY, RJ ;
CAMITTA, BM ;
TOMASULO, PA .
AMERICAN JOURNAL OF HEMATOLOGY, 1980, 8 (03) :315-324
[8]   A COLONY ASSAY SYSTEM THAT DETECTS B-CELL PROGENITORS IN FRESH AND CULTURED BONE-MARROW [J].
DORSHKIND, K ;
JOHNSON, A ;
HARRISON, Y ;
LANDRETH, KS .
JOURNAL OF IMMUNOLOGICAL METHODS, 1989, 123 (01) :93-101
[9]  
ESPANOL T, 1979, CLIN EXP IMMUNOL, V38, P615
[10]   PURIFIED HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR - DIRECT ACTION ON NEUTROPHILS [J].
GASSON, JC ;
WEISBART, RH ;
KAUFMAN, SE ;
CLARK, SC ;
HEWICK, RM ;
WONG, GG ;
GOLDE, DW .
SCIENCE, 1984, 226 (4680) :1339-1342